79 related articles for article (PubMed ID: 6668515)
1. A technique to quantify cytoreduction in the bone marrow induced by cytotoxic chemotherapy.
Blumenreich MS; Strife A; Clarkson BD
J Clin Oncol; 1983 Sep; 1(9):552-8. PubMed ID: 6668515
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia.
Hiddemann W; Clarkson BD; Büchner T; Melamed MR; Andreeff M
Blood; 1982 Feb; 59(2):216-25. PubMed ID: 7055637
[TBL] [Abstract][Full Text] [Related]
3. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
[TBL] [Abstract][Full Text] [Related]
4. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy.
Cassileth PA; Gerson SL; Bonner H; Neiman RS; Lusk EJ; Hurwitz S
J Clin Oncol; 1984 Feb; 2(2):107-11. PubMed ID: 6699661
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia.
Preisler HD; Azarnia N; Raza A; Grunwald H; Vogler R; Browman G; Goldberg J; Chervenick P; Miller K; Brennan J
Br J Haematol; 1984 Mar; 56(3):399-407. PubMed ID: 6582925
[TBL] [Abstract][Full Text] [Related]
6. Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.
Blumenreich MS; Woodcock TM; Andreeff M; Hiddemann W; Chou TC; Vale K; O'Hehir M; Clarkson BD; Young CW
Cancer Res; 1984 May; 44(5):2203-7. PubMed ID: 6713407
[TBL] [Abstract][Full Text] [Related]
7. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
[TBL] [Abstract][Full Text] [Related]
8. Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements.
Preisler HD; Priore R; Azarnia N; Barcos M; Raza A; Rakowski I; Vogler R; Winton EL; Browman G; Goldberg J
Br J Haematol; 1986 Aug; 63(4):625-36. PubMed ID: 3460626
[TBL] [Abstract][Full Text] [Related]
9. Aleukemic leukemia cutis.
Hansen RM; Barnett J; Hanson G; Klehm D; Schneider T; Ash R
Arch Dermatol; 1986 Jul; 122(7):812-4. PubMed ID: 3729513
[TBL] [Abstract][Full Text] [Related]
10. Peripheral acute leukemia: high peripheral but low-marrow blast count.
Cason JD; Trujillo JM; Estey EH; Huh YO; Freireich EJ; Stass SA
Blood; 1989 Oct; 74(5):1758-61. PubMed ID: 2790200
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of chemotherapy-induced cytoreduction in acute leukemia.
Hiddemann W; Andreeff M; Clarkson BD
Haematol Blood Transfus; 1981; 26():73-6. PubMed ID: 7319296
[No Abstract] [Full Text] [Related]
13. [Acute unclassified leukemia with bone marrow necrosis].
Uoshima N; Yamazaki N; Iinuma S; Kimura S; Wada K; Kobayashi Y; Ozawa M; Horiuchi H; Maruo N; Kondo M
Rinsho Ketsueki; 1991 Jan; 32(1):61-6. PubMed ID: 2020120
[TBL] [Abstract][Full Text] [Related]
14. Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL).
Amadori S; Petti MC; De Francesco A; Chierichini A; Mastrovincenzo C; Testa MG; Mandelli F
Cancer; 1978 Mar; 41(3):1154-60. PubMed ID: 638960
[TBL] [Abstract][Full Text] [Related]
15. Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Chappell R; Hammond D; Bleyer WA
J Clin Oncol; 1996 Feb; 14(2):389-98. PubMed ID: 8636748
[TBL] [Abstract][Full Text] [Related]
16. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.
Cassileth PA; Begg CB; Silber R; Spiers A; Burkart PT; Scharfman W; Knospe WH; Bennett JM; Mazza JJ; Oken MM
Cancer Treat Rep; 1987 Feb; 71(2):137-40. PubMed ID: 3802110
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of myelonecrosis after induction therapy in acute leukemia.
Cassileth PA; Brooks JS
Cancer; 1987 Nov; 60(10):2363-5. PubMed ID: 3311345
[TBL] [Abstract][Full Text] [Related]
18. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
[TBL] [Abstract][Full Text] [Related]
19. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
Blumenreich MS; Chou TC; Andreeff M; Vale K; Clarkson BD; Young CW
Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
